146 related articles for article (PubMed ID: 32883524)
1. Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Biochem Biophys Res Commun; 2020 Nov; 532(3):427-432. PubMed ID: 32883524
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Mol Cell Biochem; 2020 Jun; 469(1-2):89-95. PubMed ID: 32301060
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cellular functions through induction of LPA
Takahashi K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
Mol Cell Biochem; 2017 Jul; 431(1-2):29-35. PubMed ID: 28205098
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptor-2 (LPA
Takahashi K; Minami K; Otagaki S; Ishimoto K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2018 Sep; 503(4):2698-2703. PubMed ID: 30093116
[TBL] [Abstract][Full Text] [Related]
5. Effects of lysophosphatidic acid (LPA) receptor-2 (LPA
Ueda N; Minami K; Ishimoto K; Tsujiuchi T
Cell Signal; 2020 May; 69():109551. PubMed ID: 32006610
[TBL] [Abstract][Full Text] [Related]
6. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
7. Different effects of lysophosphatidic acid receptor-2 (LPA
Ishimoto K; Minami A; Minami K; Ueda N; Tsujiuchi T
J Recept Signal Transduct Res; 2021 Feb; 41(1):93-98. PubMed ID: 32672083
[TBL] [Abstract][Full Text] [Related]
8. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
9. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA
Ikeda H; Takai M; Yashiro N; Amano Y; Hara K; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 May; 257():155293. PubMed ID: 38615508
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
12. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells.
Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140
[TBL] [Abstract][Full Text] [Related]
13. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
15. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
16. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation.
Shano S; Hatanaka K; Ninose S; Moriyama R; Tsujiuchi T; Fukushima N
Biochim Biophys Acta; 2008 May; 1783(5):748-59. PubMed ID: 18157949
[TBL] [Abstract][Full Text] [Related]
17. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
18. Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells.
Ishii S; Kitamura Y; Hirane M; Tomimatsu A; Fukushima K; Takahashi K; Fukushima N; Honoki K; Tsujiuchi T
Mol Carcinog; 2016 Nov; 55(11):1553-1559. PubMed ID: 26331585
[TBL] [Abstract][Full Text] [Related]
19. Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
Kurisu R; Takamoto M; Minami K; Ueda N; Yamada M; Shima N; Otani T; Sakai Y; Kondo D; Tsujiuchi T
J Bioenerg Biomembr; 2022 Apr; 54(2):109-117. PubMed ID: 35260987
[TBL] [Abstract][Full Text] [Related]
20. LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
